title: [Treatment with octreotide of stenosing cystic dystrophy on heterotopic pancreas of the duodenal wall].
abstract: Cystic dystrophy of the duodenal wall developing in heterotopic pancreas is a rare disease. Weight loss and painless vomiting due to duodenal stenosis where the main clinical manifestations of this entity in a chronic alcoholic patient. Diagnosis was made by using an ultrasonic-endoscope equipped with a miniprobe. Although surgical treatment is usually recommended in this situation, the clinical condition of this patient improved dramatically after subcutaneous injections of somatostatin analog (octreotide). This treatment was maintained during 9 months and no recurrence was observed during the follow-up period.
authors.affiliation: Service d'Hépato-Gastroentérologie, Hôpital Avicenne, Bobigny.
authors.forename: V
authors.initials: V
authors.lastname: de Parades
authors.forename: D
authors.initials: D
authors.lastname: Roulot
authors.forename: L
authors.initials: L
authors.lastname: Palazzo
authors.forename: S
authors.initials: S
authors.lastname: Chaussade
authors.forename: P
authors.initials: P
authors.lastname: Mingaud
authors.forename: J
authors.initials: J
authors.lastname: Rautureau
authors.forename: T
authors.initials: T
authors.lastname: Coste
mesh_terms: D000328:Adult; D002828:Choristoma / Q000188:drug therapy*; D003560:Cysts / Q000188:drug therapy*; D004378:Duodenal Diseases / Q000188:drug therapy*; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D015282:Octreotide / Q000627:therapeutic use*; D010179:Pancreas
chemical_list: D005765:Gastrointestinal Agents; D015282:Octreotide